Contact The Migraine Trust press office
For comment, interviews, case studies or information on our latest news and campaigns, journalists, and broadcasters should contact the press office using the following information:
Press office contacts
Please call the media team on 07947567079 or email: email@example.com.
For urgent out-of-hours media enquiries, please contact 07947567079.
Note: These contact details are for journalists only.
Stay up to date with the latest news and stories from The Migraine Trust
Rimegepant is now approved for acute and preventative treatment of migraine on the NHS in England
Rimegepant approved for use in NHS Scotland for the acute and preventative treatment of migraine